{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T13:44:27Z","timestamp":1772631867869,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100021045","name":"Massachusetts Department of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1NU58DP007156"],"award-info":[{"award-number":["1NU58DP007156"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clml.2024.11.011","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T11:42:06Z","timestamp":1732275726000},"page":"285-292.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Socioeconomic Status and Healthcare Resource Availability on Survival in Older (\u226566 years) Non-Hispanic Black Patients Versus Non-Hispanic White Patients With Multiple Myeloma"],"prefix":"10.1016","volume":"25","author":[{"given":"Sophia S.","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4416-4897","authenticated-orcid":false,"given":"Robert","family":"Schuldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiza","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9506-7539","authenticated-orcid":false,"given":"Tu My","family":"To","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archibong","family":"Yellow-Duke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allicia","family":"Girvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelli","family":"Spence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9670-2864","authenticated-orcid":false,"given":"Joseph","family":"Mikhael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2024.11.011_bib0001","unstructured":"National Institutes of Health Surveillance, Epidiemology, and End Results Program. Cancer statistics facts: myeloma. 2023. Accessed June 19, 2024. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html."},{"key":"10.1016\/j.clml.2024.11.011_bib0002","first-page":"202","article-title":"Cancer statistics for African American\/Black People 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2024.11.011_bib0003","unstructured":"Minority population profiles - Black\/African American. U.S. Department of Health and Human Services Office of Minority Health. 2021. Accessed June 19, 2024. Available at: https:\/\/minorityhealth.hhs.gov\/blackafrican-american."},{"key":"10.1016\/j.clml.2024.11.011_bib0004","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41408-023-00961-0","article-title":"Addressing the disparities: the approach to the African American patient with multiple myeloma","volume":"13","author":"Bhutani","year":"2023","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2024.11.011_bib0005","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: a population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2024.11.011_bib0006","unstructured":"Cancer.Net multiple myeloma: statistics. 2023. Accessed June 19, 2024. Available at: https:\/\/www.cancer.net\/cancer-types\/multiple-myeloma\/statistics."},{"key":"10.1016\/j.clml.2024.11.011_bib0007","doi-asserted-by":"crossref","first-page":"10916","DOI":"10.1182\/blood-2022-158205","article-title":"Trends over time in overall survival of patients with multiple myeloma by race\/ethnicity and by comorbidity status: a surveillance, epidemiology, and end results (SEER)-medicare analysis","volume":"140","author":"Anwer","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.clml.2024.11.011_bib0008","doi-asserted-by":"crossref","first-page":"e6915","DOI":"10.1002\/cam4.6915","article-title":"Racial differences in treatment and survival among older patients with multiple myeloma","volume":"13","author":"Wang","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.clml.2024.11.011_bib0009","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1182\/bloodadvances.2021005482","article-title":"Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials","volume":"6","author":"Kanapuru","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.clml.2024.11.011_bib0010","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41408-023-00877-9","article-title":"Global disparities in patients with multiple myeloma: a rapid evidence assessment","volume":"13","author":"Mateos","year":"2023","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2024.11.011_bib0011","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41408-020-00347-6","article-title":"Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis","volume":"10","author":"Derman","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2024.11.011_bib0012","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/bloodadvances.2019000308","article-title":"Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis","volume":"3","author":"Ailawadhi","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.clml.2024.11.011_bib0013","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jtct.2022.04.008","article-title":"Socioeconomic and racial disparity in chimeric antigen receptor T cell therapy access","volume":"28","author":"Ahmed","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.clml.2024.11.011_bib0014","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.28877","article-title":"Geographic and racial disparities in access to chimeric antigen receptor-T cells and bispecific antibodies trials for multiple myeloma","volume":"5","author":"Alqazaqi","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clml.2024.11.011_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2020-142960","article-title":"Racial differences in multiple myeloma survival and treatment using pooled clinical trial and real-world electronic medical record data","volume":"136","author":"Rusli","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clml.2024.11.011_bib0016","doi-asserted-by":"crossref","first-page":"e826","DOI":"10.1016\/j.clml.2022.04.020","article-title":"Multiple myeloma: impact of time to transplant on the outcome","volume":"22","author":"Kumar","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2024.11.011_bib0017","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.clml.2020.04.018","article-title":"Racial disparities in the utilization of novel agents for frontline treatment of multiple myeloma","volume":"20","author":"Fiala","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2024.11.011_bib0018","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3109\/10428194.2015.1011156","article-title":"Socioeconomic status is independently associated with overall survival in patients with multiple myeloma","volume":"56","author":"Fiala","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2024.11.011_bib0019","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-022-00681-x","article-title":"Socioeconomic disadvantage contributes to ethnic disparities in multiple myeloma survival: a matched cohort study","volume":"12","author":"Buradagunta","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2024.11.011_bib0020","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jval.2023.03.018","article-title":"HPR7: Racialized economic segregation and inequities in survival among patients with multiple myeloma","volume":"26","author":"Pittell","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.clml.2024.11.011_bib0021","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1182\/blood-2018-99-118392","article-title":"Disparities in healthcare resource utilization for multiple myeloma","volume":"132","author":"Fiala","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2024.11.011_bib0022","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1016\/j.jval.2023.03.1364","article-title":"HSD57 treatment patterns and healthcare resource utilization in patients with relapsed\/refractory multiple myeloma (RRMM) on second and third line (2L\/3L) therapy, classified by urbanicity and ethnicity","volume":"26","author":"Molinari","year":"2023","journal-title":"Value Health"},{"key":"10.1016\/j.clml.2024.11.011_bib0023","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.2019000406","article-title":"With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study","volume":"133","author":"Fillmore","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clml.2024.11.011_bib0024","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41408-022-00633-5","article-title":"Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study","volume":"12","author":"Dong","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2024.11.011_bib0025","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clml.2023.09.009","article-title":"Overall survival in patients with multiple myeloma in the U.S.: a systematic literature review of racial disparities","volume":"24","author":"Mikhael","year":"2024","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2024.11.011_bib0026","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41408-022-00665-x","article-title":"Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data","volume":"12","author":"Maignan","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2024.11.011_bib0027","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/1475-6773.12229","article-title":"Evaluating area-based socioeconomic status indicators for monitoring disparities within health care systems: results from a primary care network","volume":"50","author":"Berkowitz","year":"2014","journal-title":"Health Serv Res"},{"key":"10.1016\/j.clml.2024.11.011_bib0028","unstructured":"2021 National Healthcare Quality and Disparities Report. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021. Access to healthcare and disparities in access. Accessed October 25, 2024. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK578537\/."},{"key":"10.1016\/j.clml.2024.11.011_bib0029","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1080\/10428194.2021.1953013","article-title":"Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study","volume":"62","author":"Al Hadidi","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2024.11.011_bib0030","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/cncr.30183","article-title":"Impact of marital status, insurance status, income, and race\/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States","volume":"122","author":"Costa","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2024.11.011_bib0031","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/16078454.2022.2026027","article-title":"The effect of marital status on the survival of patients with multiple myeloma","volume":"27","author":"Tang","year":"2022","journal-title":"Hematology"},{"key":"10.1016\/j.clml.2024.11.011_bib0032","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1038\/s41598-024-65590-4","article-title":"Multiple myeloma incidence and mortality trends in the United States, 1999\u20132020","volume":"14","author":"Zhu","year":"2024","journal-title":"Sci Rep"},{"issue":"Supplement 1","key":"10.1016\/j.clml.2024.11.011_bib0033","first-page":"S574","article-title":"MM-593 sociodemographic trends in Multiple myeloma-related mortality from 1999 to 2020 and effect of the COVID-19 pandemic","volume":"24","author":"Aijaz","year":"2024","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024024212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024024212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:38:40Z","timestamp":1772606320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024024212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2152265024024212"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.11.011","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Socioeconomic Status and Healthcare Resource Availability on Survival in Older (\u226566 years) Non-Hispanic Black Patients Versus Non-Hispanic White Patients With Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}